phosphotyrosine has been researched along with Angiogenesis, Pathologic in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Dembélé, P; Garnier, O; Martin, DK; Vilgrain, I | 1 |
| Ahn, R; Cory, S; Ha, JR; Hallett, M; Hardy, WR; Im, YK; Maric, G; Park, M; Pawson, T; Sabourin, V; Siegel, PM; Ursini-Siegel, J; Zhao, H | 1 |
| Bast, RC; Heymach, JV; Le, XF; Lu, C; Mao, W; Sood, AK; Thornton, A | 1 |
| Eliceiri, BP; Levin, EG; Lin, AH | 1 |
| Eckes, B; Gullberg, D; Iozzo, RV; Krieg, T; Nyström, A; Pozzi, A; Shaik, ZP; Zent, R | 1 |
| Alessandro, R; Corrado, C; De Leo, G; Flugy, AM; Guggino, G; Karmali, R; Raimondo, S; Taverna, S | 1 |
| Auzenne, EJ; Bast, RC; Gao, F; Klostergaard, J; Liao, WS; Lu, Z; Mandal, PK; McMurray, JS; Robertson, FM | 1 |
| Barja-Fidalgo, C; Coelho, AL; De Freitas, MS; Mariano-Oliveira, A; Selistre-de-Araújo, HS; Terruggi, CH | 1 |
| Boloor, A; Cheung, M; Crosby, RM; Crouthamel, MC; Epperly, AH; Gilmer, TM; Harrington, LE; Hopper, TM; Johnson, JH; Knick, VB; Kumar, R; Luttrell, DK; Miller, CG; Mullin, RJ; Onori, JA; Rudolph, SK; Stafford, JA; Truesdale, AT | 1 |
| Barry, ST; Copley, C; James, NH; Jürgensmeier, JM; Kendrew, J; Oakley, I; Smith, NR; Wainwright, A; Wedge, SR; Womersley, LM | 1 |
| Alessandro, R; Kohn, EC; Liotta, LA; Spoonster, J; Wersto, RP | 1 |
| Freeman, AL; Kain, R; Lindberg, RA; Ogawa, K; Pasquale, EB; Pasqualini, R | 1 |
| Babior, BM; Ellison, EC; Hunt, TK; Khanna, S; Roy, S; Sen, CK | 1 |
13 other study(ies) available for phosphotyrosine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Microtumor Spheroids Provide a Model for Studying Molecules Involved in Vascular Organization: An Illustrative Study for VE-cadherin.
Topics: Animals; Antigens, CD; Cadherins; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Neovascularization, Pathologic; Phosphorylation; Phosphotyrosine; Sunitinib; Tyrosine | 2022 |
The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Female; Fibronectins; Humans; Integrin alpha5beta1; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Mutation; Neovascularization, Pathologic; Phosphotyrosine; Protein Structure, Tertiary; Receptor Protein-Tyrosine Kinases; Shc Signaling Adaptor Proteins; Signal Transduction; Vascular Endothelial Growth Factor A | 2013 |
Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Endothelial Cells; Female; Humans; Ligands; Mice; Mice, Nude; Neovascularization, Pathologic; Pericytes; Phosphotyrosine; Placenta Growth Factor; Pregnancy Proteins; Receptor, ErbB-2; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Trastuzumab; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2008 |
FAK mediates the inhibition of glioma cell migration by truncated 24 kDa FGF-2.
Topics: Cell Line, Tumor; Cell Movement; Fibroblast Growth Factor 2; Focal Adhesion Kinase 1; Focal Adhesion Kinase 2; Glioma; Humans; Neovascularization, Pathologic; Phosphorylation; Phosphotyrosine; Serine; Tyrosine | 2009 |
Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity.
Topics: Animals; Carcinoma, Lewis Lung; Cell Adhesion; Endothelium, Vascular; Heparan Sulfate Proteoglycans; Humans; Integrin alpha1; Integrin alpha2beta1; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Neovascularization, Physiologic; Peptide Fragments; Phosphorylation; Phosphotyrosine; Protein Interaction Mapping; Protein Processing, Post-Translational; Protein Structure, Tertiary; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Receptor Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Xenograft Model Antitumor Assays | 2009 |
Carboxyamidotriazole-orotate inhibits the growth of imatinib-resistant chronic myeloid leukaemia cells and modulates exosomes-stimulated angiogenesis.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Adhesion; Cell Adhesion Molecules; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Exosomes; Extracellular Signal-Regulated MAP Kinases; Fusion Proteins, bcr-abl; Gene Expression Regulation, Leukemic; Human Umbilical Vein Endothelial Cells; Humans; Imatinib Mesylate; Interleukin-8; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Neovascularization, Pathologic; Orotic Acid; Phosphorylation; Phosphotyrosine; Piperazines; Proto-Oncogene Proteins c-akt; Pyrimidines; RNA, Messenger; Triazoles; Xenograft Model Antitumor Assays | 2012 |
A phosphopeptide mimetic prodrug targeting the SH2 domain of Stat3 inhibits tumor growth and angiogenesis.
Topics: Animals; Biomimetics; Breast Neoplasms; Female; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Phosphopeptides; Phosphorylation; Phosphotyrosine; Prodrugs; src Homology Domains; STAT3 Transcription Factor; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2012 |
Alternagin-C, a nonRGD-disintegrin, induces neutrophil migration via integrin signaling.
Topics: Actins; Active Transport, Cell Nucleus; Amino Acid Motifs; Animals; Bothrops; Cell Movement; Cell Nucleus; Chemotaxis; Cytoskeleton; Disintegrins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Matrix; Flavonoids; Humans; Immunoblotting; Immunohistochemistry; Integrins; Mitogen-Activated Protein Kinase 1; N-Formylmethionine Leucyl-Phenylalanine; Neoplasm Metastasis; Neovascularization, Pathologic; Neutrophils; Peptides; Phosphatidylinositol 3-Kinases; Phosphotyrosine; Precipitin Tests; Protein Structure, Tertiary; Signal Transduction; Snake Venoms; Time Factors | 2003 |
Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell-Free System; Cornea; Dose-Response Relationship, Drug; Female; Fibroblast Growth Factor 2; Humans; Indazoles; Inhibitory Concentration 50; Mice; Mice, Nude; Neovascularization, Pathologic; Phosphorylation; Phosphotyrosine; Protein Kinase Inhibitors; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Sulfonamides; Sulfones; Vascular Endothelial Growth Factor A | 2007 |
Acute pharmacodynamic and antivascular effects of the vascular endothelial growth factor signaling inhibitor AZD2171 in Calu-6 human lung tumor xenografts.
Topics: Animals; Antibodies, Neoplasm; Antibodies, Phospho-Specific; Antineoplastic Agents; Female; Humans; Lung Neoplasms; Mice; Mice, Nude; Neovascularization, Pathologic; Phosphorylation; Phosphotyrosine; Quinazolines; Reproducibility of Results; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2007 |
Angiogenesis: role of calcium-mediated signal transduction.
Topics: Aminoimidazole Carboxamide; Calcium; Calcium Channel Blockers; Cell Adhesion; Cell Division; Cell Movement; Cells, Cultured; Collagen; Drug Combinations; Endothelium, Vascular; Extracellular Matrix Proteins; Fibroblast Growth Factor 2; Gelatinases; Humans; In Vitro Techniques; Laminin; Matrix Metalloproteinase 2; Metalloendopeptidases; Neovascularization, Pathologic; Phosphotyrosine; Proteoglycans; Signal Transduction; Triazoles; Tyrosine | 1995 |
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.
Topics: Animals; Blotting, Western; Breast Neoplasms; Capillaries; Cells, Cultured; Collagen; Drug Combinations; Endothelium, Vascular; Ephrin-A1; Female; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Hyperplasia; Laminin; Ligands; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Neovascularization, Pathologic; Phosphotyrosine; Proteins; Proteoglycans; Receptor Protein-Tyrosine Kinases; Receptor, EphA2; Sarcoma, Kaposi; Signal Transduction; Transplantation, Heterologous; Tumor Cells, Cultured | 2000 |
Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing.
Topics: Animals; Cell Line; Collagen; Endothelial Growth Factors; Gene Deletion; Gene Transfer Techniques; Green Fluorescent Proteins; Humans; Hydrogen Peroxide; Immunoblotting; Keratinocytes; Luciferases; Luminescent Proteins; Lymphokines; Male; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; NADPH Oxidases; Neovascularization, Pathologic; Oxidants; Oxidation-Reduction; Phosphotyrosine; Plasmids; Precipitin Tests; Promoter Regions, Genetic; rac1 GTP-Binding Protein; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleases; Skin; Skin Physiological Phenomena; Time Factors; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Wound Healing | 2002 |